Woo Yong Bae1, So Hyang Kim2, Min Young Kang2, Tae Kyung Koh2. 1. Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Dong-A University, Busan, Republic of Korea. Electronic address: doncamel@dau.ac.kr. 2. Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Dong-A University, Busan, Republic of Korea.
Abstract
OBJECTIVE: The microscopic transcolumellar transseptal transsphenoidal approach (TSA) is the one of the most widely used methods for the surgical treatment of sellar and parasellar lesions. But nasal and paranasal sinus inflammation is the relative contraindications of TSA. This study was performed to investigate the results of pre TSA treatment options according to the degree of nasal and paranasal sinus inflammation on the paranasal sinus computed tomography scan (PNS CT). METHODS: From January 2005 to September 2010, 145 consecutive patients underwent operation of pituitary lesions through the TSA. The preoperative CT images for these patients were reviewed, and 26 patients were identified with sinus opacification on PNS CT. We then analyzed presenting symptoms, physical and endoscopic examination, Lund-Mackay score on PNS CT and preoperative management of the sinus problem retrospectively. RESULTS: Twenty-six patients had sinus opacification on PNS CT. Eight patients had the symptoms of sinusitis corresponding to PNS CT finding, so they had therapeutic antibiotics, and had TSA after symptomatic improvement. Three patients had the symptoms of sinusitis and sinus opacification with mean Lund-Mackay score of 5.33, so they underwent endoscopic sinus surgery first, and they got TSA a few months after. One patient underwent endoscopic sinus surgery and TSA simultaneously. No patient had a serious complication including intracranial infection. CONCLUSION: TSA is a relatively safe technique, but intracranial complication after surgery may be fatal. Therefore rigorous evaluation and management is mandatory. It is especially important to treat rhinosinusitis issues preoperatively. Our preliminary data may be helpful to evaluate and manage the paranasal sinus inflammation before TSA.
OBJECTIVE: The microscopic transcolumellar transseptal transsphenoidal approach (TSA) is the one of the most widely used methods for the surgical treatment of sellar and parasellar lesions. But nasal and paranasal sinus inflammation is the relative contraindications of TSA. This study was performed to investigate the results of pre TSA treatment options according to the degree of nasal and paranasal sinus inflammation on the paranasal sinus computed tomography scan (PNS CT). METHODS: From January 2005 to September 2010, 145 consecutive patients underwent operation of pituitary lesions through the TSA. The preoperative CT images for these patients were reviewed, and 26 patients were identified with sinus opacification on PNS CT. We then analyzed presenting symptoms, physical and endoscopic examination, Lund-Mackay score on PNS CT and preoperative management of the sinus problem retrospectively. RESULTS: Twenty-six patients had sinus opacification on PNS CT. Eight patients had the symptoms of sinusitis corresponding to PNS CT finding, so they had therapeutic antibiotics, and had TSA after symptomatic improvement. Three patients had the symptoms of sinusitis and sinus opacification with mean Lund-Mackay score of 5.33, so they underwent endoscopic sinus surgery first, and they got TSA a few months after. One patient underwent endoscopic sinus surgery and TSA simultaneously. No patient had a serious complication including intracranial infection. CONCLUSION:TSA is a relatively safe technique, but intracranial complication after surgery may be fatal. Therefore rigorous evaluation and management is mandatory. It is especially important to treat rhinosinusitis issues preoperatively. Our preliminary data may be helpful to evaluate and manage the paranasal sinus inflammation before TSA.
Authors: Jake J Lee; Brian C Deutsch; Dorina Kallogjeri; Patrik Pipkorn; John S Schneider; Cristine N Klatt-Cromwell Journal: Am J Otolaryngol Date: 2021-09-01 Impact factor: 1.808
Authors: Juan Á Aibar-Durán; Michael Oladotun-Anka; Carlos Asencio-Cortés; Elena Valassi; Susan Webb; Juan R Gras-Cabrerizo; Joan Monserrat-Gili; Pere Tresserras Ribó; Fernando Muñoz-Hernández Journal: J Neurol Surg B Skull Base Date: 2021-03-02